Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Beta_herpesvirinae
|
| gptkbp:belongs_to |
Herpesviridae family
|
| gptkbp:can_lead_to |
gptkb:healthcare_organization
|
| gptkbp:caused_by |
neurological disorders
cytomegalovirus infection retinitis congenital infection |
| gptkbp:communication |
bodily fluids
|
| gptkbp:established |
foscarnet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Human cytomegalovirus
|
| gptkbp:is_associated_with |
gptkb:computer
hearing loss birth defects graft rejection increased risk of stroke gastrointestinal disease neurodevelopmental delays |
| gptkbp:is_characterized_by |
latent infection
|
| gptkbp:is_considered |
ubiquitous in human populations
a leading cause of congenital disabilities a major cause of morbidity a significant public health concern |
| gptkbp:is_known_for |
cause opportunistic infections
evade immune response affect fetal development reactivate in immunosuppressed patients cause long-term health issues. cause severe disease in neonates cause systemic infections induce cellular proliferation interfere with antiviral immunity |
| gptkbp:is_linked_to |
gptkb:hospital
autoimmune diseases chronic kidney disease cognitive impairment pulmonary complications increased mortality in transplant patients mononucleosis-like syndrome |
| gptkbp:is_often_used_in |
pregnant women
elderly populations immunocompromised individuals HIV-positive individuals organ transplant recipients infants with congenital infection |
| gptkbp:is_protected_by |
antiviral medications
|
| gptkbp:is_related_to |
other herpesviruses
|
| gptkbp:is_studied_in |
therapeutic interventions
clinical research vaccine efficacy vaccine development diagnostic methods therapeutic vaccines pathogenesis |
| gptkbp:recognizes |
gptkb:healthcare_organization
breast milk saliva urine PCR testing |
| gptkbp:treatment |
ganciclovir
|